Aarey Drugs & Pharmaceuticals Ltd - Stock Valuation and Financial Performance

BSE: 524412 | NSE: AAREYDRUGS | Pharmaceuticals & Drugs | Small Cap

Aarey Drugs & Pharma Share Price

63.43 1.20 1.93%
as on 03-Dec'24 16:59

DeciZen - make an informed investing decision on Aarey Drugs & Pharma

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Semi Strong

Aarey Drugs & Pharmaceuticals stock performance -

mw4me loader
P/E Ratio (SA):
25.69
Market Cap:
177.1 Cr.
52-wk low:
37
52-wk high:
75.8

Is Aarey Drugs & Pharmaceuticals Ltd an attractive stock to invest in?

1. Is Aarey Drugs & Pharmaceuticals Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aarey Drugs & Pharmaceuticals Ltd is a below average quality company.

2. Is Aarey Drugs & Pharmaceuticals Ltd undervalued or overvalued?

The key valuation ratios of Aarey Drugs & Pharmaceuticals Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Aarey Drugs & Pharmaceuticals Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Aarey Drugs & Pharmaceuticals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Aarey Drugs & Pharma:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Aarey Drugs & Pharmaceuticals Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 6.7%7.2%22.2%14.1%12.1%8.5%9.5%9.9%6.3%6.1%-
Value Creation
Index
-0.5-0.50.60.0-0.1-0.4-0.3-0.3-0.6-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 213246396349355300348493419396519
Sales YoY Gr.-15.3%60.9%-12%1.7%-15.4%16.1%41.4%-15%-5.6%-
Adj EPS 0.60.832.62.82.52.82.61.61.72.4
YoY Gr.-20.6%297.4%-15.6%9.4%-11.1%12.1%-7.6%-37.4%3.7%-
BVPS (₹) 2121.826.633.33638.541.343.945.346.548.2
Adj Net
Profit
1.11.35.566.55.86.56.54.14.77
Cash Flow from Ops. 3.35.70.6-20.40.72.95.50.5-1.3-3-
Debt/CF from Ops. 3.42.616.6-0.223.56.33.328.4-29.4-10.5-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 7.1%2.2%4.3%-5.6%
Adj EPS 11.4%-9.8%-15.6%3.7%
BVPS9.2%5.2%4%2.5%
Share Price 15.6% 28% 18.9% 35%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
33.512.79.27.86.56.86.13.53.85.1
Op. Profit
Mgn %
0.60.42.42.22.21.11.32.321.11.2
Net Profit
Mgn %
0.50.51.41.71.81.91.91.311.21.3
Debt to
Equity
0.30.40.200.20.20.20.10.30.20
Working Cap
Days
17916611214814719120916622126084
Cash Conv.
Cycle
7362463745438588436

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 5.10%

Sales growth is good in last 4 quarters at 71.57%

Sales growth has been subdued in last 3 years 4.33%

Net Profit has been subdued in last 3 years -15.62%

Latest Financials - Aarey Drugs & Pharmaceuticals Ltd.

Standalone Consolidated
TTM EPS (₹) 2.4 -
TTM Sales (₹ Cr.) 519 -
BVPS (₹.) 48.2 -
Reserves (₹ Cr.) 109 -
P/BV 1.29 -
PE 25.69 -
From the Market
52 Week Low / High (₹) 37.00 / 75.75
All Time Low / High (₹) 0.50 / 143.95
Market Cap (₹ Cr.) 177
Equity (₹ Cr.) 28.5
Face Value (₹) 10
Industry PE 44.7

Management X-Ray of Aarey Drugs & Pharma:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Aarey Drugs & Pharma

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales213246396349355300348493419396
Operating Expenses 212245386341347297344481411391
Manufacturing Costs01002259811
Material Costs210242383337341290334466398375
Employee Cost 0000000111
Other Costs 2233354654
Operating Profit 111088351184
Operating Profit Margin (%) 0.6%0.4%2.4%2.2%2.2%1.1%1.3%2.3%1.8%1.1%
Other Income 3333477337
Interest 1242222234
Depreciation 1111111222
Exceptional Items 0000000000
Profit Before Tax 12889781065
Tax 0132212321
Profit After Tax 1156767745
PAT Margin (%) 0.5%0.5%1.4%1.8%1.8%1.9%1.9%1.3%0.9%1.2%
Adjusted EPS (₹)0.70.83.02.62.82.52.82.61.51.7
Dividend Payout Ratio (%)0%0%0%0%4%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 35374878849097111115130
Share Capital 17171823232323252528
Reserves 192030556167738690102
Minority Interest0000000000
Debt1115103161818143831
Long Term Debt0000000343
Short Term Debt1114103161818113328
Trade Payables677275783778110110127129
Others Liabilities 12911888101113
Total Liabilities 115125142170146194233245291303

Fixed Assets

Gross Block17192425262730323334
Accumulated Depreciation11111213141516181921
Net Fixed Assets681212121214141413
CWIP 0000000000
Investments 0000000001
Inventories42515211718142935
Trade Receivables6772829510696162136190184
Cash Equivalents 0213011012
Others Assets3841424466837805868
Total Assets 115125142170146194233245291303

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 361-201350-1-3
PBT 12889781065
Adjustment 3253333445
Changes in Working Capital -11-10-29-9-6-5-10-9-12
Tax Paid 00-2-3-2-2-2-4-2-1
Cash Flow From Investing Activity -2-3-5-1-1-1-3-30-2
Capex -2-3-5-1-1-1-3-2-1-1
Net Investments 0000000-11-1
Others 0000000000
Cash Flow From Financing Activity -1-2423-2-2-2216
Net Proceeds from Shares 007240008011
Net Proceeds from Borrowing 0000000-44-1
Interest Paid -1-2-4-2-2-2-2-2-3-4
Dividend Paid 0000000000
Others 0012000001
Net Cash Flow -11-12-300011
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)3.123.5812.99.88.076.656.986.313.333.82
ROCE (%)6.697.2322.2114.1412.058.489.469.876.286.09
Asset Turnover Ratio1.922.052.962.242.251.771.632.061.561.33
PAT to CFO Conversion(x)360.2-3.330.140.50.710-0.25-0.6
Working Capital Days
Receivable Days1121037193103123135110142173
Inventory Days85310192319121929
Payable Days1141057082617210386109125

Aarey Drugs & Pharmaceuticals Ltd Stock News

Aarey Drugs & Pharmaceuticals Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Aarey Drugs & Pharma on 03-Dec-2024 16:59 is ₹63.43.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Dec-2024 16:59 the market cap of Aarey Drugs & Pharma stood at ₹177.1.
The latest P/E ratio of Aarey Drugs & Pharma as of 03-Dec-2024 16:59 is 25.69.
The latest P/B ratio of Aarey Drugs & Pharma as of 03-Dec-2024 16:59 is 1.29.
The 52-week high of Aarey Drugs & Pharma is ₹75.75 and the 52-week low is ₹37.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Aarey Drugs & Pharma is ₹518.9 ( Cr.) .

About Aarey Drugs & Pharmaceuticals Ltd

Aarey Drugs & Pharmaceuticals Ltd. was established in 1990. The company is engaged in the manufacturing of drugs and intermediates such as metronidazole, metronidazole benzoate, methyl, and nitro imidazole. The company is based in Thane, India.

The  company also export its products to various other countries like Germany, Sri Lanka, Pakistan, Nepal and a number of African countries and is looking to establish its trade relations in other parts of the world as well.

Product range of the company includes: API/Intermediate

  • Metronidazol
  • Metronidazole Benzoate
  • 2 Methyl -5-Nitro Imidazole

Drug deliveryPharmaceuticals / Therapeutics

Therapeutic targets of the company's products are:

  • Allergy
  • Dermatology
  • Infectious Diseases

Recent development

Aarey Drugs & Pharmaceuticals  has recently informed that  Atul A Zatakia has resigned from the Company as a Director with effect from March 01, 2009.  

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.